In our study, the cut-off for anti-DSG2-ab positivity was assessed based upon an exclusively internal validation evaluation; further studies and external validation are needed to validate these reference values for anti-DSG-2 positivity in ARVC and other cardiac and extracardiac diseases cohorts. Here, DSG2 is linked to Arrhythmogenic right ventricular dysplasia.